lobbying_activities: 3195344

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3195344	3c925461-95af-4d68-9a7c-0997064e0507	Q2	IPOLICY SOLUTIONS	401105127	ASSOCIATION FOR MOLECULAR PATHOLOGY	2024	second_quarter	MED	No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests"	HOUSE OF REPRESENTATIVES,SENATE	70500		0	0	2024-07-17T09:50:48-04:00